VITA Accelerator

VITA Accelerator represents the dedicated Digital Health division within CDP National Accelerators Network, established through a strategic collaboration between CDP Venture Capital SGR, EVERSANA, and Accelerace. The program has been specifically designed to provide comprehensive support for startups either headquartered in Italy or looking to establish operations within the Italian market. With its deep industry connections and specialized resources, VITA offers early-stage digital health companies access to funding, mentorship, and market entry strategies tailored to the unique regulatory landscape of European healthcare.

At its core, VITA's mission extends beyond individual startup success to the broader development of Italy's digital health ecosystem. The accelerator works systematically to strengthen local innovation capabilities, foster connections between entrepreneurs and established healthcare institutions, and elevate the international profile of Italian digital health innovations. This dual focus on company-specific growth and ecosystem development positions VITA as a catalyst for healthcare transformation in Southern Europe, addressing critical challenges in patient care, clinical efficiency, and healthcare accessibility.

The accelerator benefits from powerful strategic partnerships that enhance its value proposition for portfolio companies. Innovation Partner Zcube contributes cutting-edge research capabilities and pharmaceutical industry connections, while Corporate Partners SIFI and Petrone Group provide domain expertise in ophthalmology and pharmaceutical distribution respectively. This corporate engagement is complemented by VITA's extensive network of Ecosystem Partners including leading hospitals, patient advocacy organizations, and specialized digital health hubs across Italy, creating a comprehensive support infrastructure for participating startups.

VITA's investment approach typically focuses on pre-seed to Series A companies developing innovative solutions across telemedicine, AI diagnostics, digital therapeutics, and healthcare workflow optimization. The accelerator provides initial investments ranging from €100,000 to €300,000, with possibilities for follow-on funding for high-performing portfolio companies. Beyond capital, VITA delivers a structured 6-month acceleration program featuring personalized mentoring, regulatory guidance, clinical validation opportunities, and international market expansion support. This comprehensive approach has established VITA as a premier launchpad for digital health innovation in the Mediterranean region.